Courses by faculty: Faculty of Pharmacy and Pharmaceutical Sciences

In this course you will learn about the chemistry, biology and technology of medicines and other chemical formulations and how to improve human health and well-being by researching and developing more reliable, accessible and effective treatments and products. You will develop the knowledge and practical skills critical to the discovery and development of new drugs and therapies leading to exciting careers in research and industry.

During the first 18 months you will develop your understanding of the foundations of pharmaceutical science and of the relationships between the different disciplines and their distinct roles in drug discovery and development. This will prepare you to choose your specialisation from one of the following fields:

• Formulation science: the invention, manufacture and testing of new products such as pharmaceuticals, food and cosmetics
• Medicinal chemistry: the principles and techniques behind drug discovery and development
• Drug discovery biology: the discovery and understanding of biological drug targets, and their modulation by chemicals and other substances

You will then develop specialist knowledge and techniques and your understanding of the application of pharmaceutical methods and professional practices required in the workplace. You will study with one of largest and most productive group of pharmaceutical researchers in Australia, the Monash Institute of Pharmaceutical Sciences, and you will graduate having worked in industry-standard facilities, such as our Shimadzu high-pressure liquid chromatography (HPLC) lab.

In your final year you will gain practical skills through a major research project or industry placement and be ready for a career in pharmaceutical research, the biomedical industry and many other fields that require advanced chemical-formulation skills. Formulation Science will prepare you for a range of careers in developing pharmaceuticals, food, cosmetics, agricultural chemicals, veterinary products, paints and inks and many other consumer goods; Medicinal Chemistry will prepare you for a range of industrial, academic and commercial career paths; and Drug Discovery Biology will prepare you for a career in translating the information and outcomes of drug development studies into pharmaceutical products.

Double degrees

The Bachelor of Pharmaceutical Science course, with the Formulation science specialisation, can be taken in combination with the following course:

• Bachelor of Engineering (Honours) (only with the specialisation of Chemical Engineering)

This will lead to the award of two degrees, the Bachelor of Pharmaceutical Science and the Bachelor of Chemical Engineering. The requirements for the award of each of the degrees will be fulfilled in part by cross crediting of units required in the separate courses. Students should refer to the course entry for the Bachelor of Engineering (Honours) for the requirements for the Chemical Engineering specialisation.

Specialisations

Formulation science

This field involves formulating, designing and evaluating pharmaceuticals and other products and explores the transformation of the active drug compounds into a finished product. This includes design, generation and evaluation of new pharmaceutical products and applications beyond, such as foods and personal products.

Medicinal chemistry

This field is at the intersection of biology and chemistry and involves the study of how drugs work and how they are designed and made. Medicinal chemistry applies the principles and techniques of chemistry to discover and develop compounds that prevent, treat or cure disease. It's a feedback process of design, synthesis and biological testing to optimise the potency, selectivity and absorption in the body of a compound, while minimising side effects.

Drug discovery biology

This field focuses on the biomedical science and pharmacology of drug discovery, with an understanding of biological drug targets, and their modulation by all types of active drug compounds. It explores the biotechnological aspects of drug design and evaluation, including discovering and evaluating new targets for testing drugs; the biological effects of drug candidates, and translating outcomes into pharmaceutical products

These course outcomes are aligned with the Australian Qualifications Framework level 7, the Bologna Cycle 1 and Monash Graduate AttributesAustralian Qualifications Framework level 7, the Bologna Cycle 1 and Monash Graduate Attributes (http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).

Upon successful completion of this course it is expected that you will:

1. have acquired broad theoretical knowledge of pharmaceutical sciences and advanced knowledge of one of the specialisations: Drug discovery biology, Formulation science or Medicinal chemistry. In particular,
• Drug discovery biology specialists will appreciate the mechanisms of drug action based on interactions at molecular, cellular and organ level, identify the appropriate research methods required for the evaluation of new drug targets, and evaluate candidate novel therapeutic agents based on affinity/efficacy profiles.
• Medicinal chemistry specialists will understand and apply the principles of drug action, design and implement approaches to synthesising bioactive molecules, and analyse chemical structures and interactions using computational, spectroscopic and analytical techniques.
• Formulation science specialists will be capable of designing drug delivery systems for all types of active molecules, understand processes that contribute to the product life cycle, possess analytical skills to assess the physical, and chemical properties of active molecules and delivery systems, and have knowledge to evaluate the suitability of these formulations within the context of industrial and regulatory environments.
2. be able to solve problems by applying appropriate experimental design, scientific thinking, evidence-based approaches and data analysis
3. have mastered the range of practical and analytical skills and techniques relevant to modern research and industrial laboratory environments
4. be aware of technologies and developments shaping the pharmaceutical sciences
5. possess vocational skills for professional practice within the pharmaceutical and related industries
6. be equipped to participate in lifelong learning
7. be able to demonstrate critical analysis, numeracy, information literacy, leadership skills and communication of, and about, science
8. be able to appreciate and respect the ethical, legal and social responsibilities of a scientist in an international context.

The course develops through three themes. The first two, foundation science studies and pharmaceutical science studies culminate in an applied project.

Part A. Foundation science studies

Foundation studies in bioorganic and medicinal chemistry, physical chemistry and physiology will underpin further studies in your chosen specialisation. It will also provide an introduction to the key areas of scientific communication and practice and scientific research methodology.

Part B. Pharmaceutical science

This will provide you with practical and theoretical skills and knowledge of your specialisation. You will learn to develop, apply and communicate the concepts and theoretical frameworks that constitute the knowledge base of your chosen discipline.

Part C. Applied project

The studies in parts A. and B. culminate in a major research project (medicinal chemistry; drug discovery biology) or industry placement (formulation science).

The course comprises 144 points of pharmaceutical science study.

The course develops through theme studies in: A. Foundation science, B. Pharmaceutical science and C. Applied project.

The course progression mapcourse progression map (http://www.monash.edu.au/pubs/2016handbooks/maps/map-p2001.pdf) will assist you to plan to meet the course requirements, and guidance on unit enrolment for each semester of study.

Units are six credit points unless otherwise stated.

Common first three semesters (72 points)

Part A. Foundation sciences

Students complete:

• PSC1011 Physiology I
• PSC1021 Bioorganic and medicinal chemistry I
• PSC1031 Physical chemistry I
• PSC1012 Physiology II
• PSC1022 Bioorganic and medicinal chemistry II
• PSC1032 Physical chemistry II
• PSC2011 Biochemical pharmacology*
• PSC2021 Structural organic chemistry*
• PSC2031 Analytical methods*
• PSC2041 Biopharmaceutics

* Students in the double degree course with Chemical Engineering do not complete these units since Engineering studies provide the knowledge and skills.

Part B. Pharmaceutical science

Students complete:

• PSC1041 Scientific Inquiry
• PSC1042 Introduction to pharmaceutical sciences

Specialist formulation science study (72 points)

Part B./C. Pharmaceutical science and applied project

Student complete:

• PSC2012 Molecular pharmacology*
• PSC2222 Formulation chemistry
• PSC2232 Colloid chemistry

One of the following units:

• PSC2122 Synthetic organic chemistry
• PSC2132 Introduction to spectroscopy
• PSC2142 Computational chemistry

Plus the following units:

• PSC3211 Industrial formulation
• PSC3221 Biomolecule formulation and modified release technology*
• PSC3231 Pharmaceutical product manufacture
• PSC3041 Applied analytical methods
• PSC3212 Product Commercialisation*
• PSC3222 Advanced formulations and nanotechnologies

One of the following units:*

• PSC3322 Current aspects of cancer biology
• PSC3112 Drug discovery and development
• PSC3142 Computational drug design

Plus the following unit:

• PSC3232 Industry placement*

* Students in the double degree course with chemical engineering do not complete these units since engineering studies provide the knowledge and skills.

Specialist medicinal chemistry study (72 points)

Part B./C. Pharmaceutical science and applied project

Student complete:

• PSC2012 Molecular pharmacology
• PSC2122 Synthetic organic chemistry
• PSC2132 Introduction to spectroscopy
• PSC2142 Computational chemistry
• PSC3111 Molecular basis of drug action
• PSC3121 Advanced synthetic chemistry
• PSC3131 Medicinal analysis of drug receptor interactions
• PSC3041 Applied analytical methods
• PSC3112 Drug discovery and development
• PSC3122 Synthetic medicinal chemistry
• PSC3142 Computational drug design
• PSC3132 Medicinal chemistry research project

Specialist drug discovery biology study (72 points)

Part B./C. Pharmaceutical science and applied project

Student complete:

• PSC2012 Molecular pharmacology
• PSC2322 Molecular cell biology
• PSC2332 Disease focused pharmacology - peripheral

One of the following units:

• PSC2122 Synthetic organic chemistry
• PSC2132 Introduction to spectroscopy
• PSC2142 Computational chemistry
• PSC2222 Formulation chemistry

Plus the following units:

• PSC3311 Microbiology and immunology
• PSC3321 Disease focused pharmacology - CNS
• PSC3111 Molecular basis of drug action
• PSC3041 Applied analytical methods
• PSC3112 Drug discovery and development
• PSC3322 Current aspects of cancer biology
• PAC3512 Current aspects of pharmaceutical research
• PSC3332 Drug delivery research project

Students successfully completing the Bachelor of Pharmaceutical Science may proceed to a one year honours program leading to the Bachelor of Pharmaceutical Science (Honours). To be eligible to apply for entry into the Bachelor of Pharmaceutical Science (Honours), students must achieve an overall distinction grade average (70 percent) or higher in the final year of the course.

This is an advanced version of the Bachelor of Pharmaceutical Science that is designed for high-achieving students who expect to pursue honours studies and a career in pharmaceutical science: the science of medicines. A flexible course, it covers the multi-disciplinary chemical and biological science base used in researching and developing reliable, accessible and effective medicinal products.

A pharmaceutical scientist is trained to select new targets for drug therapy that arise from basic research. As a pharmaceutical scientist you will have the scientific and technical knowledge to translate new targets into reliable, accessible and effective treatments for patients.

During the first 18 months you will develop your understanding of the foundations of pharmaceutical science and of the relationships between the different disciplines and their distinct roles in drug discovery and development. This will prepare you to choose your specialisation from one of the following fields:

• Formulation science: the invention, manufacture and testing of new products such as pharmaceuticals, food and cosmetics
• Medicinal chemistry: the principles and techniques behind drug discovery and development
• Drug discovery biology: the discovery and understanding of biological drug targets, and their modulation by chemicals and other substances

You will then develop specialist knowledge and techniques and your understanding of the application of pharmaceutical methods and of professional practices in the workplace and the laboratory. The course encourages the development of strong research, communication, life-long learning and team work skills and provides practical and theoretical training in planning, undertaking and documenting scientific research projects.

You will study with one of largest and most productive group of pharmaceutical researchers in Australia, the Monash Institute of Pharmaceutical Sciences and you will graduate having worked in industry-standard facilities, such as to our Shimadzu high-pressure liquid chromatography (HPLC) laboratory, and will be well prepared for postgraduate study or for employment in the global pharmaceutical industry.

Specialisations

Formulation science

This field involves formulating, designing and evaluating pharmaceuticals and other products and explores the transformation of the active drug compounds into a finished product. This includes the design, generation and evaluation of new pharmaceutical products and applications beyond, such as foods and personal products.

Medicinal chemistry

This field is at the intersection of biology and chemistry and involves the study of how drugs work and how they are designed and made. Medicinal chemistry applies the principles and techniques of chemistry to discover and develop compounds that prevent, treat or cure disease. It's a feedback process of design, synthesis and biological testing to optimise the potency, selectivity and absorption in the body of a compound, while minimising side effects.

Drug discovery biology

This field focuses on the biomedical science and pharmacology of drug discovery, with an understanding of biological drug targets, and their modulation by all types of active drug compounds. It explores the biotechnological aspects of drug design and evaluation, including discovering and evaluating new targets for testing drugs; the biological effects of drug candidates, and translating outcomes into pharmaceutical products.

These course outcomes are aligned with the Australian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate AttributesAustralian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate Attributes (http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).

Upon successful completion of this course it is expected that you will:

1. have acquired broad theoretical knowledge of pharmaceutical sciences and advanced knowledge in your specialisations. In particular,
• Drug discovery biology specialists will appreciate the mechanisms of drug action based on interactions at molecular, cellular and organ level, identify the appropriate research methods required for the evaluation of new drug targets, and evaluate candidate novel therapeutic agents based on affinity/efficacy profiles.
• Medicinal chemistry specialists will understand and apply the principles of drug action, design and implement approaches to synthesising bioactive molecules, and analyse chemical structures and interactions using computational, spectroscopic and analytical techniques.
• Formulation science specialists will be capable of designing drug delivery systems for all types of active molecules, understand processes that contribute to the product life cycle, possess analytical skills to assess the physical, and chemical properties of active molecules and delivery systems, and have knowledge to evaluate the suitability of these formulations within the context of industrial and regulatory environments.
2. apply a problem-led approach to engage the subject at multidisciplinary, translational and vocational levels, being aware of technologies and developments shaping the pharmaceutical sciences to provide future higher degree candidates or leaders in industry
3. have technical discipline and practical skills as foundations for research, including research planning in conjunction with a project supervisor, experimental techniques, data analysis, scientific writing, competent use of analytical instrumentation, conducting experimental procedures and methodologies, data manipulation and analysis, and understanding the interpretation of data, plus an appreciation of innovation, creative thinking and disruptive processes.
4. possess professional and vocational skills for pharmaceutical and related industries, including communication skills, critical analysis, numeracy, information literacy, team and leadership skills.
5. appreciate and respect the ethical, legal and social responsibilities of a scientist in an international context, including the basics of intellectual property.

Refer to the undergraduate credit transfer policyundergraduate credit transfer policy (http://intranet.monash.edu.au/pharm/students/undergrad/policy/credit.html).

96 credit points

In third year students who specialise in formulation science undertake a work placement in industry as part of the unit PSC3232 (Industry-linked research project).

The course includes all the requirements of the Bachelor of Pharmaceutical Science, developing through three themes. The first two, foundation science studies and pharmaceutical science studies, culminate in an honours research project.

Part A. Foundation science studies

Foundation studies in bioorganic and medicinal chemistry, physical chemistry and physiology will underpin further studies in your chosen specialisation. It will also provide an introduction to the key areas of scientific communication and practice and scientific research methodology.

Part B. Pharmaceutical science studies

This will provide you with practical and theoretical skills and knowledge of your specialisation. You will learn to develop, apply and communicate the concepts and theoretical frameworks that constitute the knowledge base of your chosen discipline.

Part C. Honours research program

The studies in A. and B. culminate in an honours research program that will extend your discipline knowledge and provide you with a high level of expertise in critical writing, thinking and independent analysis and research.

The course comprises 192 points of Pharmaceutical science units.

The course develops through theme studies in: A. Foundation science, B. Pharmaceutical science and C. Honours research project.

To remain in the course you are required to achieve at least a distinction average (70%) across all units by the end of the third year of the degree.

In addition, in order to progress to the fourth year, you must normally complete 144 credit points. You must also achieve a minimum of a distinction average (70 per cent) in 24 credit points of level three units in the relevant pharmaceutical science specialisation.,

If you do not meet this standard you will be course completed with the Bachelor of Pharmaceutical Science

The course progression mapcourse progression map (http://www.monash.edu.au/pubs/2016handbooks/maps/map-p3002.pdf) will assist you to plan to meet the course requirements, and guidance on unit enrolment for each semester of study.

Units are six credit points unless otherwise stated.

Common first three semesters (72 points)

Part A. Foundation science studies

Students complete:

• PSC1011 Physiology I
• PSC1021 Bioorganic and medicinal chemistry I
• PSC1031 Physical chemistry I
• PSC1012 Physiology II
• PSC1022 Bioorganic and medicinal chemistry II
• PSC1032 Physical chemistry II
• PSC2011 Biochemical pharmacology
• PSC2021 Structural organic chemistry
• PSC2031 Analytical methods
• PSC2041 Biopharmaceutics

Part B. Pharmaceutical science studies

Students complete:

• PSC1041 Scientific Inquiry
• PSC1042 Introduction to pharmaceutical sciences

Specialist formulation science study (60 points)

Part B. Pharmaceutical science

Student complete:

• PSC2012 Molecular pharmacology
• PSC2222 Formulation chemistry
• PSC2232 Colloid chemistry

One of the following units:

• PSC2122 Synthetic organic chemistry
• PSC2132 Introduction to spectroscopy
• PSC2142 Computational chemistry

Plus the following units:

• PSC3211 Industrial formulation
• PSC3221 Biomolecule formulation and modified release technology
• PSC3231 Pharmaceutical product manufacture
• PSC3041 Applied analytical methods
• PSC3212 Product commercialisation
• PSC3222 Advanced formulations and nanotechnologies

Specialist medicinal chemistry study (60 points)

Part B. Pharmaceutical science

Student complete:

• PSC2012 Molecular pharmacology
• PSC2122 Synthetic organic chemistry
• PSC2132 Introduction to spectroscopy
• PSC2142 Computational chemistry
• PSC3111 Molecular basis of drug action
• PSC3121 Advanced synthetic chemistry
• PSC3131 Medicinal analysis of drug receptor interactions
• PSC3041 Applied analytical methods
• PSC3112 Drug discovery and development
• PSC3122 Synthetic medicinal chemistry

Specialist drug discovery biology study (60 points)

Part B./C. Pharmaceutical science and applied project

Student complete:

• PSC2012 Molecular pharmacology
• PSC2322 Molecular cell biology
• PSC2332 Disease focused pharmacology - peripheral

One of the following units:

• PSC2122 Synthetic organic chemistry
• PSC2132 Introduction to spectroscopy
• PSC2142 Computational chemistry
• PSC2222 Formulation chemistry

Plus the following units:

• PSC3311 Microbiology and immunology
• PSC3321 Disease focused pharmacology - CNS
• PSC3111 Molecular basis of drug action
• PSC3041 Applied analytical methods
• PSC3112 Drug discovery and development
• PSC3322 Current aspects of cancer biology

Part C. Honours research program (60 points)

Students complete the pre honours research project (12 points) specified for their specialisation in semester 2 of their third year and the remaining units (48 points) in their final year.

Formulation science

• PSC3532 Formulation science pre honours research project (12 points)
• PSC4211 Advanced formulation science (12 points)
• PSC4212 Research in formulation science (36 points)

Medicinal chemistry

• PSC3432 Medicinal chemistry pre honours research project (12 points)
• PSC4111 Advanced medicinal chemistry 12 points)
• PSC4112 Research in medicinal chemistry (36 points)

Drug discovery biology

• PSC3532 Drug discovery biology pre honours research project (12 points)
• PSC4311 Advanced drug discovery biology (12 points)
• PSC4312 Research in drug discovery biology (36 points)

Minimum grade for course completion

Students in this course are required to maintain at least a distinction average of 70 per cent or above as their weighted average mark (WAM) to remain in the course. The average is a cumulative course average. Should the WAM fall below the required standard students will be transferred to 2894 Bachelor of Pharmaceutical Science.

Pharmacists make a difference to people's health in hospitals, aged-care facilities and local communities. In the Bachelor of Pharmacy (Honours) you will learn about the formulation of medicines and their impact on the body. The course provides you the knowledge, experience and expertise you need to make a difference from the moment you graduate as a medicines expert and healthcare professional.

Very high achieving students can apply to be admitted to the Bachelor of Pharmacy (Honours) Scholars Program offered at the Parkville campus. The Scholars Program gives you opportunities not available to all students, including extra academic and professional mentoring from pharmacy graduates, leadership training through the Ambassador program and a Dean's Scholarship (if you are an Australian or New Zealand citizen or holder of an Australian permanent resident or permanent humanitarian visa).

As a Pharmacy student at our Parkville campus, you will learn from experienced pharmacists and researchers in some of the country's best-equipped facilities. You'll have access to innovative teaching technologies, such as 'MyDispense', a web-based program that combines over 300 virtual patients and 1500 pharmacy products to provide authentic dispensing practice, and 'Pharmatopia', a virtual hi-tech teaching tool, developed by us and adopted by leading pharmacy schools around world.

During third and fourth year, you will undertake work placements in hospitals and community pharmacies through the professional experience placement program. The program provides an understanding of the processes involved in, for example, providing primary health care, drug information, and clinical pharmacy services in different practice environments.

Our Bachelor of Pharmacy (Hons) course is accredited by the Australian Pharmacy Council. To become a registered pharmacist, you must first complete the Bachelor of Pharmacy (Honours) degree, then undertake a period of supervised practice in accordance with the requirements set out by the Pharmacy Board of Australia, while also completing an internship training program which is accredited by the Australian Pharmacy Council. Monash University offers an Australian Pharmacy Council accredited internship program, either as a stand-alone course or as part of course 3460 Graduate Certificate in Pharmacy Practice (Internship). Monash University is not responsible for finding or organising internship positions for our graduates.

These course outcomes are aligned with the Australian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate AttributesAustralian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate Attributes (http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).

Upon successful completion of this course it is expected that you will have:

1. an in-depth understanding and knowledge of the enabling sciences, applied pharmaceutical sciences, clinical pharmacy and pharmacy practice and the ability to integrate and apply the knowledge to the practice of pharmacy
2. the relevant entry skills defined by the current National Competency Standards Framework for Pharmacists in Australia and requirements of future practice
3. the relevant generic skills, such as oral and written communication, critical thinking, inquiry, learning for life, numeracy and information literacy, and leadership
4. the relevant professional and social values, attitudes and behaviours necessary for practice
5. the ability to apply the knowledge and skills gained to promote and contribute to the quality use of medicines and to the health of the community.

Refer to the undergraduate credit transfer policyundergraduate credit transfer policy (http://intranet.monash.edu.au/pharm/students/undergrad/policy/credit.html).

Graduate entry is available for students with a completed undergraduate degree in a related science course, specifically a Bachelor of Biomedical Science. A credit precedence is set for students entering the course through this pathway, as they must enter into the summer intensive unit PAC1001 (Introduction to Pharmacy) prior to entering the third year of the course. This pathway is only open to eligible graduate students with a relevant completed degree prior to entering the third year of the course. The relevant completed degree must have been completed no more than ten years prior to application.

96 credit points

Special requirements

Police and Working with Children checks are required for the professional experience placements in clinical and community settings in the Bachelor of Pharmacy. All students will be required to obtain and pay for a police check and Working with Children check prior to undertaking the clinical and community placements in their course.

Before commencing their professional experience placements students are required to show records that they have been immunised in line with the Department of Human Services' list of immunisation for health workers.

For further information or for clarification contact the placement program coordinator at pep@monash.edu.

During third and fourth year students undertake work placements in hospitals and community pharmacies through the professional experience placement programprofessional experience placement program (http://intranet.monash.edu.au/pharm/students/placements/index.html).

Pharmacy Board of Australia

To practice as a pharmacist in Victoria it is necessary to register with the Pharmacy Board of Australia. To qualify for registration with the Pharmacy Board of Australia, a period of internship practical training must be undertaken after completing this undergraduate course. Refer to the faculty's Registration as a pharmacist page in this Handbook.

Royal Australian Chemical Institute

Bachelor of Pharmacy graduates from Monash University are eligible to become members of the Royal Australian Chemical Institute (RACI) after a period of practical experience. RACI members are able to practise in many areas of industry as professional chemists and receive the salaries determined by the RACI.

The course develops through the four themes, the first three being enabling science, pharmaceutics and pharmacy practice which come together in the fourth, integrated therapeutics.

Part A. Enabling science

These studies will provide you with the foundational understanding and knowledge of the enabling sciences, developing your understanding of the human body and of the chemistry, biochemistry, physiology, and pharmacology underlying the development and administration of pharmaceuticals.

Part B. Pharmaceutics

These studies will equip you with fundamental and applied knowledge required to understand and assess pre-formulation, formulation, manufacturing and packaging of pharmaceutical products. This includes the understanding and application of the time course of how medicines get absorbed, distributed and eliminated from the body and drug response in the body.

Part C. Pharmacy practice

These studies will equip you with the sociocultural context in which the pharmacist and the client operate, social and health practice issues, ethical, legal context of pharmacy, relevant professional and social values, attitudes and behaviours necessary for practice. It will develop the communication and practical skills to apply the knowledge and skills you have gained to promote and contribute to the quality use of medicines and to the health of the community.

Part D. Integrated therapeutics

These studies will provide you with knowledge about diseases, disorders and their management. You will develop an understanding and application of the relationship between pathophysiology and the rational design and clinical use of drugs in the management of various health conditions. You will apply the knowledge and critical thinking skills gained in the enabling sciences, pharmaceutics and pharmacy practice to optimise pharmacotherapy in clinical practice.

In addition:

Part E. Elective study

One elective unit in pharmacy.

The course comprises 192 points of pharmacy study.

The course develops through theme studies in: A. Enabling science, B. Pharmaceutics, C. Pharmacy practice, and D. Integrated therapeutics.

Note that students in the Scholars Program are required to maintain at least a distinction average (70 per cent) each semester. If you do not meet this standard you will be required to transfer to the Bachelor of Pharmacy (Honours) stream.

The course progression mapcourse progression map (http://www.monash.edu.au/pubs/2016handbooks/maps/map-p3001.pdf) will assist you to plan to meet the course requirements, and guidance on unit enrolment for each semester of study.

Units are six credit points unless otherwise stated.

Part A. Enabling science (48 points)

Students complete:

• PAC1111 Introduction to physiology
• PAC1121 Bioorganic and medicinal chemistry I
• PAC1132 Systems physiology
• PAC1142 Bioorganic and medicinal chemistry II
• PAC1211 Physicochemical basis of pharmacy
• PAC2151 Biochemistry and molecular biology
• PAC2161 Cell function, communication and pathology
• PAC3191 Microbiology and immunology

Part B. Pharmaceutics (42 points)

Students complete:

• PAC1222 Drug delivery I
• PAC2171 Basis of drug action I
• PAC2182 Basis of drug action II
• PAC2232 Drug delivery and disposition
• PAC3241 Drug delivery, disposition and dynamics
• PAC3252 Drug delivery II
• PAC4261 Drug delivery and development

Part C. Pharmacy practice (54 points)

Students complete:

• PAC1311 Pharmacy, health and society I
• PAC1322 Pharmacy, health and society II
• PAC2342 Pharmacy in a public health context
• PAC3351 Context for practice I
• PAC3362 Context for practice II
• PAC4382 Context for practice III
• PAC2331 Pharmacists as communicators
• PAC4482 Preparation for practice
• PAC4371 Professional experience placement program

Part D Integrated therapeutics (42 points)

Students complete:

• PAC2412 Integrated therapeutics: Introduction and cardiovascular
• PAC3421 Integrated therapeutics respiratory and gastrointestinal disease
• PAC3432 Integrated therapeutics: Infectious diseases
• PAC4441 Integrated therapeutics: Endocrinology and renal
• PAC4451 Integrated therapeutics: Dermatology and pain
• PAC4462 Integrated therapeutics: Neurology and oncology
• PAC4472 Integrated therapeutics: Mental Health

Part E. Elective study (6 points)

Students complete one unit from:

• PAC3512 Current aspects of pharmaceutical research
• PAC3522 Applied research project
• PAC3542 Leadership

Combining chemical engineering with pharmaceutical science, this double degree course is unique in Australia and rare worldwide.

Chemical engineers can design, run and troubleshoot production facilities, but their training typically excludes the skills to develop pharmaceutical and related products. Similarly, formulation scientists can invent and test new products such as pharmaceuticals, food and cosmetics, but they lack the know-how to manage the product process beyond the laboratory stage.

This course combines chemical engineering and pharmaceutical science to produce professionals capable of covering the full spectrum of the pharmaceutical product design and development process.

Pharmaceutical engineers work in all aspects of the design and development process, from experimenting with innovative formulations to manufacturing commercialized products. A pharmaceutical engineer might:

• Design, develop and improve industrial processes and equipment for large scale chemical and pharmaceutical manufacturing.
• Plan and test methods of manufacturing.
• Develop methods for the treatment of by-products.
• Devise production processes that are safe, efficient, profitable and environmentally sound.
• Research naturally occurring chemical reactions and copy these processes for society's benefit.
• Develop and implement cleaner production technologies.
• Design, develop and use new materials.

Double degree courses include the features of the component degree courses, except that electives may be reduced.

Engineering

E3001 Bachelor of Engineering (Honours) is a specialist course that develops through four themes that combine to underpin engineering practice: Fundamentals and foundational skills, Design, Knowledge and applications, and Professional Practice.

Part A. Engineering fundamentals and foundational skills

These will develop your understanding of natural and physical sciences, mathematics, numerical analysis, statistics, and computer and information sciences that underpin all engineering disciplines.

Part B. Engineering design

This will develop the engineering techniques, tools and resources for the conduct, design and management of engineering design processes and projects, both in the industrial setting and in the development of research experiments.

Part C. Engineering knowledge and application

This will provide in-depth knowledge of the specific engineering methods of a branch of engineering, and will integrate the specific engineering methods and discipline knowledge into practice. You will develop skills to identify and apply knowledge of contextual factors impacting the engineering discipline. Additionally, your studies will focus on your understanding and application of the scope, principles, norms, accountabilities and bounds of contemporary engineering practice in your discipline.

Part D. Professional practice

This will develop your skills in readiness for the engineering workplace. You will develop skills in effective team membership and team leadership, the use and management of commercially relevant data, and the legal responsibilities of engineers. This study will integrate the theme 'Engineering knowledge and application' with your specialist field of engineering.

Pharmaceutical science

P2001 Bachelor of Pharmaceutical Science is a specialist course that develops through three themes. The first two, foundation science studies and pharmaceutical science studies culminate in an applied project.

Part A. Foundation science studies

Foundation studies in bioorganic and medicinal chemistry, physical chemistry and physiology will underpin further studies in your chosen specialisation. It will also provide an introduction to the key areas of scientific communication and practice and scientific research methodology.

Part B. Pharmaceutical science

This will provide you with practical and theoretical skills and knowledge of your specialisation. You will learn to develop, apply and communicate the concepts and theoretical frameworks that constitute the knowledge base of your chosen discipline.

Part C. Applied project

The studies in A. and B. culminate in a major research project (Medicinal chemistry and Drug discovery biology) or industry placement (Formulation Science).

Students must complete 240 points, of which 144 points are from the Bachelor of Engineering (Honours) (including all of the requirements in Part A, B, C and D for the single degree) and 96 points from the Bachelor of Pharmaceutical Science (including all of the requirements in Part A, B and C from the single degree).

The course progression mapcourse progression map (http://www.monash.edu.au/pubs/2016handbooks/maps/map-e3008.pdf) will assist you to plan to meet the course requirements, and guidance on unit enrolment for each semester of study.

Units are six credit points unless otherwise stated.

Students may be eligible to exit the double degree program and graduate with either a Bachelor of Chemical Engineering or a Bachelor of Pharmaceutical Science after 3 or 4 years, depending on the units studied.

Students who wish to graduate with a Bachelor of Chemical Engineering prior to the completion of the double degree must have completed at least 192 points of studies, including all of the requirements in Part A, B, C and D for the Bachelor of Chemical Engineering degree. Students who wish to graduate with a Bachelor of Pharmaceutical Science prior to the completion of the double degree must have completed at least 144 points of studies, including all of the requirements in Part A, B and C for the Bachelor of Pharmaceutical Science degree.

This is a prestigious program of coursework and research in pharmaceutical science for high achieving students who have completed a relevant undergraduate degree. You will undertake research methodology training and carry out an independent research project on your selected topic, working closely with a supervisor who will provide you with individual guidance and academic counselling. The course offers a pathway to higher level research in pharmaceutical science.

Studies can be undertaken within the general research themes of:

• medicinal chemistry
• drug discovery biology
• drug delivery, disposition and dynamics (formulation science)
• medicine use and safety

With permission of the Graduate Research Committee, it may also be possible to undertake a portion of the research in an external institution such as a hospital or industry laboratory. If a substantial portion of the research work is to be carried out in an external institution you will have an internal supervisor from the faculty and an associate supervisor from the relevant institution.

Specialisations

• Drug discovery biology
• Formulation science
• Medicine use and safety
• Medicinal chemistry

These course outcomes are aligned with the Australian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate AttributesAustralian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate Attributes (http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).

Upon successful completion of this course it is expected that you will be able to:

1. work independently to undertake a scientific literature review and work collaboratively to design, develop and implement a research project
2. collect, organise, manipulate, analyse and interpret data meaningfully using experimental and computational approaches
3. develop, apply, integrate and generate knowledge in professional contexts to analyse challenges and to develop effective solutions
4. demonstrate technical competence to use analytical instrumentation, conduct experimental procedures and methodologies in laboratory based disciplines
5. communicate ideas and results effectively to diverse audiences and in a variety of formats.

This course consists of a combination of coursework and research. In the coursework component you will develop advanced theoretical and/or technical knowledge of the area of research focus within Pharmaceutical Science, that is, medicinal chemistry, drug discovery biology, formulation science and medicine use and safety. In the research component you will develop research methodologies appropriate to your focus and plan and execute a research project under the guidance of at least one academic supervisor.

This course comprises 48 points including Research (36 points) and Coursework (12 points).

Drug discovery biology

• PSC4312 Research in drug discovery biology (36 points)
• PSC4311 Advanced drug discovery biology (12 points)

Formulation science

• PSC4212 Research in formulation science (36 points)
• PSC4211 Advanced formulation science (12 points)

Medicine use and safety

• PSC4412 Research in medicine use and safety (36 points)
• PSC4411 Advanced medicine use and safety (12 points)

Medicinal chemistry

• PSC4112 Research in medicinal chemistry (36 points)
• PSC4111 Advanced medicinal chemistry (12 points)

Satisfactory completion of this course may provide credit toward a Monash Masters by coursework degree and provides the preparation necessary to undertake a Masters by research degree or a Doctorate (PhD) degree although admission depends upon results.

This course allows students to develop further knowledge and skills in a range of pharmacy practice-related areas. It provides an opportunity for ongoing professional development at the same time as earning an additional qualification.

Students can specialise in specific areas of practice by undertaking elective units which cover pharmacy practice, clinical pharmacy, economics and wound care relevant to pharmacy.

These course outcomes are aligned with the Australian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate AttributesAustralian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate Attributes (http://monash.edu/pubs/handbooks/alignmentofoutcomes.html).

Upon successful completion of this course it is expected that graduates will be capable of:

• consolidating and building upon the knowledge, skills, attitudes and experiences gained as an undergraduate
• applying the knowledge and skills to day-to-day pharmacy practice situations
• further developing the technical, clinical, personal and professional skills that form the basis of pharmacy practice
• further developing problem-solving skills and application of professional judgement in patient care
• working within the ethical and legal framework of the profession
• exploring personal career goals and expectations
• dealing with professional and personal pressures associated with being a pharmacist
• becoming a 'life-long learner'.

12 credit points

Students who choose the elective unit PGP5015 (Geriatric pharmacy practice) are required to undertake patient medication history interviews and medication reviews in the student's workplace. Home Medicines Review are to be conducted under the supervision of an accredited consultant pharmacist or hospital outreach pharmacist (assistance is available with organising this for students located in Victoria if the student does not have access to a suitably experienced pharmacist).

Successful completion of PGP5015 (Geriatric pharmacy practice) is recognised by the Australian Association of Consultant Pharmacy (AACP) for Stage 1 of the training program for accreditation of pharmacists to deliver Commonwealth-funded Medication Management Reviews.

This course consists of one core 6-point unit and 18 points of elective units.

Students must complete the following core unit:

• PGC5001 Evidence based practice

plus 18 points from the following electives:

• ECC5970 Introduction to health economics*
• ECC5971 Pharmaceutical economics*
• ECC5973 Economic evaluation in healthcare*
• ECC5975 Principles of health economics for developing countries*
• MPH5020 Introduction to epidemiology and biostatistics*
• PGC5002 Patient data and pharmacotherapy 1**
• PGC5003 Patient data and pharmacotherapy 2**
• PGC5004 Patient data and pharmacotherapy 3**
• PGC5005 Journal club
• PGC5007 Introduction to clinical research
• PGC5010 Infectious diseases pharmacotherapy
• PGP5013 Dermatology
• PGP5014 Clinical educator preparation
• PGP5015 Geriatric pharmacy practice
• PGP5016 Geriatric disease state management
• PGP5017 Mental health
• PGP5018 Palliative care
• PGW5101 Biology of wound healing
• PGW5102 Wound assessment
• PGW5103 Wound dressings
• PGW5104 Management of acute wounds
• PGW5105 Management of chronic wounds
• PGW5106 Systemic medication and wound healing
• up to 12 credit points of complementary units

* Students cannot undertake more than 12 points of these units.

** Enrolment in these units is subject to approval. Students are also required to be working in an Australian hospital clinical setting.

Minimum grade for articulation

In order to progress to 3470 Graduate Diploma in Clinical Pharmacy or 3454 Master of Clinical Pharmacy or 3467 Master of Pharmacy Practice, students must achieve a minimum pass grade as follows:

• credit (60) average overall.

This course provides the opportunity to complete an Intern Training Program accredited by the Australian Pharmacy Council and to credit this towards a postgraduate qualification. In addition to the internship program component, students can undertake further study in specific areas of practice by undertaking elective units which cover pharmacy practice, clinical pharmacy, economics and wound care relevant to pharmacy.

These course outcomes are aligned with the http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.htmlhttp://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html (http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html)[Australian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate Attributes]].

Upon successful completion of this course it is expected that graduates will be able to:

1. consolidate and build upon the knowledge, skills, attitudes and experiences gained as an undergraduate
2. apply knowledge and skills to day-to-day pharmacy practice situations
3. integrate and further develop the technical, clinical, personal and professional skills that form the basis of pharmacy practice
4. demonstrate problem-solving skills and application of evidence based (research informed) professional judgements in a range of patient care situations
5. work within the ethical and legal framework of the profession
6. articulate and plan to achieve personal career goals and expectations
7. manage the professional and personal pressures associated with being a pharmacist
8. demonstrate the skills of a 'life-long learner'.

The Graduate Certificate in Pharmacy Practice (Internship) is an approved course of study for the purpose of registration by the Pharmacy Board of Australia. The course is structured in two parts comprising an intern training program and elective study.

The course comprises 24 points structured into two parts. Part A. Pharmacy Intern Training Program (12 points) and part B. Advanced elective study (12 points).

The course progression mapcourse progression map (http://www.monash.edu.au/pubs/2016handbooks/maps/map-p4001.pdf) will assist you to plan to meet the course requirements, and guidance on unit enrolment for each semester of study.

Students complete:

Part A. Intern Training Program

Students complete two units (12 points):

• PGP5011 Applied pharmacy practice 1
• PGP5012 Applied pharmacy practice 2

Part B. Advanced study

Students complete two units (12 points) from the following:

• ECC5970 Introduction to health economics
• ECC5971 Pharmaceutical economics
• ECC5973 Economic evaluation in healthcare
• ECC5975 Principles of health economics for developing countries
• MPH5020 Introduction to epidemiology and biostatistics
• PGC5001 Evidence based practice
• PGC5002 Patient data and pharmacotherapy 1
• PGC5005 Journal club
• PGC5010 Infectious diseases pharmacotherapy
• PGP5013 Dermatology
• PGP5014 Clinical educator preparation
• PGP5015 Geriatric pharmacy practice
• PGP5016 Geriatric disease state management
• PGP5017 Mental health
• PGP5018 Palliative care
• PGP5021 Foundation practice 1*
• PGP5022 Foundation Practice 2*
• PGW5101 Biology of wound healing
• PGW5102 Wound assessment
• PGW5103 Wound dressings
• PGW5104 Management of acute wounds
• PGW5105 Management of chronic wounds
• PGW5106 Systemic medication and wound healing
• up to 12 credit points of complementary unit**

* To enrol in this unit students must be working under the supervision of a Monash Credentialed Pharmacy Preceptor, trained through a program of Monash Credentialed Workplace Learning, at a Monash Credentialed Workplace

** Units will be assessed by the course director, to ensure the proposed units are not substantially similar to units offered within the faculty and offer equivalency of content and learning outcomes, and whether there is significant educational advantage for the proposed program of study.

In order to progress to 3470 Graduate Diploma in Clinical Pharmacy or 3454 Master of Clinical Pharmacy or 3467 Master of Pharmacy Practice, students must achieve a minimum credit (60) average overall.

This course is designed to provide the knowledge and skills to enable health professionals to effectively manage acute and chronic wounds.

These course outcomes are aligned with the Australian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate AttributesAustralian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate Attributes (http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).

Upon successful completion of this course it is expected that graduates will be able to:

• demonstrate an understanding of the physical, psychosocial and environmental components of a comprehensive wound assessment
• develop an understanding of the process of wound healing
• identify and describe factors that affect the rate of wound healing
• understand the classification and appropriate use of modern wound dressings
• critically appraise innovative new technologies in wound dressings
• communicate professionally with peers and clients with respect to wound care

12 credit points

This course consists of core units (18 points) and elective units (6 points).

Core units

Students must complete:

• PGW5101 Biology of wound healing
• PGW5102 Wound assessment
• PGW5103 Wound dressings
• PGW5104 Management of acute wounds
• PGW5105 Management of chronic wounds

Elective units

Students must complete 6 points from the following:

• PGW5109 Dermatology
• PGW5111 Alternative therapies
• PGW5112 Scar management
• PGW5113 Non-healing ulcers and pain management
• PGW5116 Diabetic foot
• PGW5123 Management of burns
• PGW5126 Clinical risk management and wound care
• PGW5130 Pressure injury prediction, prevention and management

Minimum grade for articulation

In order to progress to 2984 Graduate Diploma in Wound Care, students must achieve a minimum pass grade as follows:

• a mimimum of credit (60) in all units.

This course allows students to develop further knowledge and skills in a range of pharmacy practice-related areas. It provides an opportunity for ongoing professional development at the same time as earning an additional qualification. Students can specialise in specific areas of practice by undertaking elective units which cover pharmacy practice, clinical pharmacy, economics and wound care relevant to pharmacy.

These course outcomes are aligned with the Australian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate AttributesAustralian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate Attributes (http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).

Upon successful completion of this course it is expected that graduates will be capable of:

• apply principles of quality use of medicines to patient care within specified clinical contexts
• use relevant evidence-based principles to guide clinical practice
• demonstrate a high level of critical analysis, problem solving, decision making and professional communication related to provision of clinical pharmacy services
• use critical evaluation of literature to guide patient care
• demonstrate a high level of clinical, personal and professional skills that form the basis of pharmacy practice.

24 credit points

Students who choose the elective unit PGP5015 (Geriatric pharmacy practice) are required to undertake patient medication history interviews and medication reviews in the student's workplace. Home Medicines Review are to be conducted under the supervision of an accredited consultant pharmacist or hospital outreach pharmacist (assistance is available with organising this for students located in Victoria if the student does not have access to a suitably experienced pharmacist).

Successful completion of PGP5015 (Geriatric pharmacy practice) is recognised by the Australian Association of Consultant Pharmacy (AACP) for Stage 1 of the training program for accreditation of pharmacists to deliver Commonwealth-funded Medication Management Reviews.

This course consists of two core 6-point units and 36 points of elective units.

Students must complete the following core units:

• PGC5001 Evidence-based practice
• PGC5002 Patient data and pharmacotherapy 1

plus 36 points from the following electives:

• ECC5970 Introduction to health economics*
• ECC5971 Pharmaceutical economics*
• ECC5973 Economic evaluation in healthcare*
• ECC5975 Principles of health economics for developing countries*
• MPH5020 Introduction to epidemiology and biostatistics*
• PGC5003 Patient data and pharmacotherapy 2** or PGC5010 Infectious diseases pharmacotherapy
• PGC5004 Patient data and pharmacotherapy 3**
• PGC5005 Journal club
• PGC5007 Introduction to clinical research
• PGP5013 Dermatology
• PGP5014 Clinical educator preparation
• PGP5015 Geriatric pharmacy practice
• PGP5016 Geriatric disease state management
• PGP5017 Mental health
• PGP5018 Palliative Care
• PGW5101 Biology of wound healing
• PGW5102 Wound assessment
• PGW5103 Wound dressings
• PGW5104 Management of acute wounds
• PGW5105 Management of chronic wounds
• PGW5106 Systemic medication and wound healing
• up to 12 credit points of complementary units.

* Students cannot undertake more than 12 points of these units.

** Enrolment into this elective is subject to approval. Students are also required to be working in an Australian hospital clinical setting.

Minimum grade for articulation

In order to progress to 3454 Master of Clinical Pharmacy, students must achieve a minimum pass grade as follows:

(a.) credit (60) average overall

(b.) credit (65) in:

• MPH5020 Introduction to epidemiology and biostatistics
• PGC5001 Evidence based practice

In order to progress to 3467 Master of Pharmacy Practice, students must achieve a minimum pass grade as follows:

• credit (60) average overall.

Students wishing to exit this course early may apply to graduate with one of the following, provided they have satisfied the requirements for that award:

• 3460 Graduate Certificate in Pharmacy Practice (Internship)
• 3468 Graduate Certificate in Pharmacy Practice.

This course is designed to provide the knowledge and skills to enable health professionals to effectively manage acute and chronic wounds. The course builds on 2982 Graduate Certificate in Wound Care, and students have the opportunity to undertake elective units relevant to their area of practice.

These course outcomes are aligned with the Australian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate AttributesAustralian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate Attributes (http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).

Upon successful completion of this course it is expected that graduates will be able to:

• demonstrate high level problem-solving skill for clients with complex wounds
• utilise a systematic approach to perform an advanced assessment of a client with a wound
• develop and communicate an appropriate plan of wound care in collaboration with the client and the multidisciplinary team
• demonstrate clinical competency in practical wound care techniques
• evaluate and communicate the outcomes of care for clients with complex wounds.

24 credit points

The core unit PGW5127 (Practical wound care training and assessment) requires students to attend a five-day on-campus/residential course at the Parkville campus. They will undertake supervised clinic observation and seminar workshops (theoretical and practical) in various aspects of wound-related topics during this time.

This course consists of nine core units (36 points) and elective units (12 points).

Core units

Students must complete:

• PGC5001 Evidence based practice
• PGW5101 Biology of wound healing
• PGW5102 Wound assessment
• PGW5103 Wound dressings
• PGW5104 Management of acute wounds
• PGW5105 Management of chronic wounds
• PGW5106 Systemic medication and wound healing
• PGW5108 Nutrition and wound healing
• PGW5127 Practical wound care training and assessment

Elective units

Students must complete 12 points from the following:

• PGP5014 Clinical educator preparation
• PGW5109 Dermatology
• PGW5111 Alternative therapies
• PGW5112 Scar management
• PGW5113 Non-healing ulcers and pain management
• PGW5116 Diabetic foot
• PGW5123 Management of burns
• PGW5126 Clinical risk management and wound care
• PGW5130 Pressure injury prediction, prevention and management

Minimum grade for course completion

In order to successfully complete this course, students must achieve a minimum pass grade of credit (60) in each of the following units:

• PGW5101 Biology of wound healing
• PGW5102 Wound assessment
• PGW5103 Wound dressings
• PGW5104 Management of acute wounds
• PGW5105 Management of chronic wounds
• elective unit(s) equivalent to 6 credit points

Minimum grade for articulation

In order to progress to 2985 Master of Wound Care, students must achieve a minimum pass grade as follows:

(a.) credit (60) in:

• PGW5101 Biology of wound healing
• PGW5102 Wound assessment
• PGW5103 Wound dressings
• PGW5104 Management of acute wounds
• PGW5105 Management of chronic wounds
• PGW5106 Systemic medication and wound healing and
• PGW5108 Nutrition and wound healing
• elective unit(s) equivalent to 12 credit points

(b.) credit (65) in PGC5001 Evidence based practice

(c.) distinction (70) in PGW5127 Practical wound care training and assessment.

Students wishing to exit this course early or who do not achieve the minimum pass grade for course completion exit with the following, provided they have satisfied the requirements for this award:

• 2982 Graduate Certificate in Wound Care after successful completion of 24 points of study.

The course is designed to enable students to establish skills in evidence-based practice, quality use of medicine, practice-based research, and the provision of clinical pharmacy services at a high level.

These course outcomes are aligned with the Australian Qualifications Framework level 9, the Bologna Cycle 2 and Monash Graduate AttributesAustralian Qualifications Framework level 9, the Bologna Cycle 2 and Monash Graduate Attributes (http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).

Upon successful completion of this course it is expected that graduates will be able to:

• demonstrate a high level of critical analysis, problem solving, decision making and professional communication related to provision of clinical pharmacy services
• apply principles of quality use of medicines to patient care
• use evidence-based principles to guide clinical practice
• critically evaluate literature to develop research proposals
• undertake practice-based research projects
• effectively and appropriately communicate clinical and research information with a range professional colleagues and clients.

Successful applicants who have commenced or completed other postgraduate programs in clinical pharmacy may apply for credit for relevant prior studies. Credit will be determined on an individual basis after a review of units completed and course documentation.

24 credit points

This course requires four weeks of placement in a specialty area under the supervision of an experienced specialty clinical pharmacist preceptor approved by the course director. The placement may be undertaken in a four-week block, or as two blocks each of two weeks. It is expected that all four weeks will be carried out in the same specialty area of practice. Placements should not generally be undertaken in the student's normal workplace.

Students must be working as clinical pharmacists with access to patients in order to undertake the 'Patient data and pharmacotherapy' units as they are required to contribute cases for discussion and documentation in their learning portfolio.

This course consists of core units including a four-week speciality rotation with an experienced clinical preceptor and completion of a practice-based research project in one of the following areas of study:

• biostatistics
• epidemiology
• pharmacotherapy and interpretation of clinical data
• practice-based research
• theory and practice of evidence-based medicine.

Great importance is placed on active student participation in seminar presentations and discussion groups, and student performance is closely monitored.

Students require access to patients for case studies on a regular basis and must be working in their clinical position for the duration of each semester.

Students must complete the following units:

• MPH5020 Introduction to epidemiology and biostatistics
• PGC5001 Evidence-based practice
• PGC5002 Patient data and pharmacotherapy 1
• PGC5003 Patient data and pharmacotherapy 2
• PGC5004 Patient data and pharmacotherapy 3
• PGC5005 Journal club or PGP5014 Clinical educator preparation
• PGC5006 Specialty clinical placement
• PGC5007 Introduction to clinical research
• PGC5008 Clinical research 2
• PGC5009 Clinical research 3

Students who completed one or more of the above core units through 3460 Graduate Certificate in Pharmacy Practice (Internship), 3468 Graduate Certificate in Pharmacy Practice or 3470 Graduate Diploma in Clinical Pharmacy, whose credit towards the Master of Clinical Pharmacy was not approved, must enrol in one or more of the following elective units in order to complete the total number of credit points required to complete this award:

• ECC5970 Introduction to health economics*
• ECC5971 Pharmaceutical economics*
• ECC5973 Economic evaluation in healthcare*
• ECC5975 Principles of health economics for developing countries*
• PGC5005 Journal club or PGP5014 Clinical educator preparation
• PGP5013 Dermatology
• PGP5015 Geriatric pharmacy practice
• PGP5016 Geriatric disease state management
• PGP5017 Mental health
• PGP5018 Palliative care
• PGP5019 Advanced practice portfolio
• PGW5101 Biology of wound healing
• PGW5102 Wound assessment
• PGW5103 Wound dressings
• PGW5104 Management of acute wounds
• PGW5105 Management of chronic wounds
• PGW5106 Systemic medication and wound healing
• up to 12 credit points of complementary units

* Students cannot undertake more than 12 points of these units.

Minimum grade for course completion

In order to successfully complete this course, students must achieve a minimum pass grade as follows:

• 65 per cent in units PGC5001 (Evidence-based practice) and MPH5020 (Introduction to epidemiology and biostatistics).

Students wishing to exit this course early or who do not achieve the minimum pass grade for course completion exit with one of the following, provided they have satisfied the requirements for that award:

• 3460 Graduate Certificate in Pharmacy Practice (Internship)
• 3468 Graduate Certificate in Pharmacy Practice
• 3470 Graduate Diploma in Clinical Pharmacy.

This course is designed to enable students to develop a deep and more specialised range of attributes than those able to be acquired in the undergraduate pharmacy program. Students will be able to select units related to various advanced areas of pharmacy practice, for example aspects of clinical practice, wound care, and health economics.

It is envisaged that students will articulate into this course from 3468 Graduate Certificate in Pharmacy Practice or 3460 Graduate Certificate in Pharmacy Practice (Internship) to further their professional development, however, direct entry is also an option for registered pharmacists.

These course outcomes are aligned with the Australian Qualifications Framework level 9, the Bologna Cycle 2 and Monash Graduate AttributesAustralian Qualifications Framework level 9, the Bologna Cycle 2 and Monash Graduate Attributes (http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).

Upon successful completion of this course it is expected that graduates will be capable of:

• demonstrating an advanced level of clinical, personal and professional skills that form the basis of pharmacy practice
• demonstrating an advanced level of critical analysis, problem solving, decision making and professional communication related to provision of pharmacy services
• demonstrating an advanced level of problem-solving skills and application of professional judgement in patient care
• demonstrating leadership and innovation in day-to-day pharmacy practice situations
• using evidence-based principles to guide their practice
• critically evaluating literature to guide patient care.

24 credit points

Students who choose the elective unit PGP5015 (Geriatric pharmacy practice) are required to undertake patient medication history interviews and medication reviews in the student's workplace. Home Medicines Review are to be conducted under the supervision of an accredited consultant pharmacist or hospital outreach pharmacist (assistance is available with organising this for students located in Victoria if the student does not have access to a suitably experienced pharmacist).

Successful completion of PGP5015 (Geriatric pharmacy practice) is recognised by the Australian Association of Consultant Pharmacy (AACP) for Stage 1 of the training program for accreditation of pharmacists to deliver Commonwealth-funded Medication Management Reviews.

This course consists of two 6-point core units and 36 points of elective units.

Students must complete the following core units:

• PGC5001 Evidence-based practice
• PGP5019 Advanced practice portfolio

plus 36 points from the following electives:

• ECC5970 Introduction to health economics*
• ECC5971 Pharmaceutical economics*
• ECC5973 Economic evaluation in healthcare*
• ECC5975 Principles of health economics for developing countries*
• MPH5020 Introduction to epidemiology and biostatistics*
• PGC5002 Patient data and pharmacotherapy 1**
• PGC5003 Patient data and pharmacotherapy 2** or PGC5010 Infectious diseases pharmacotherapy
• PGC5004 Patient data and pharmacotherapy 3**
• PGC5005 Journal club
• PGC5007 Introduction to clinical research
• PGP5013 Dermatology
• PGP5014 Clinical educator preparation
• PGP5015 Geriatric pharmacy practice
• PGP5016 Geriatric disease state management
• PGP5017 Mental health
• PGP5018 Palliative Care
• PGW5101 Biology of wound healing
• PGW5102 Wound assessment
• PGW5103 Wound dressings
• PGW5104 Management of acute wounds
• PGW5105 Management of chronic wounds
• PGW5106 Systemic medication and wound healing
• up to 12 credit points of complementary units.

* Students cannot undertake more than 12 points of these units.

** Enrolment into this elective is subject to approval. Students are also required to be working in an Australian hospital clinical setting.

Students wishing to exit this course early may apply to graduate with one of the following, provided they have satisfied the requirements for that award:

• 3460 Graduate Certificate in Pharmacy Practice (Internship)
• 3468 Graduate Certificate in Pharmacy Practice
• 3470 Graduate Diploma in Clinical Pharmacy.

This course allows students to expand on and consolidate their theoretical knowledge and practical skills in wound care and management. Candidates undertake compulsory units in epidemiology/biostatistics and evidence-based practice and develop research skills by undertaking a clinical project.

These course outcomes are aligned with the Australian Qualifications Framework level 9, the Bologna Cycle 2 and Monash Graduate AttributesAustralian Qualifications Framework level 9, the Bologna Cycle 2 and Monash Graduate Attributes (http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).

Upon successful completion of this course it is expected that graduates will be able to:

• demonstrate a high level of critical analysis, problem solving, decision making and professional communication related to the care of clients with complex wounds
• utilise an evidential basis for clinical decision-making in the management of people with wounds
• demonstrate an understanding of the consequences of acute and chronic wounds from an individual and population health perspective
• demonstrate leadership, professional communication and innovation in wound care underpinned by continuous quality improvement framework.

36 credit points

The core unit PGW5127 (Practical wound care training and assessment) requires students to attend a five-day on-campus/residential course at the Parkville campus. They will undertake supervised clinic observation and seminar workshops (theoretical and practical) in various aspects of wound related topics during this time.

This course consists of core units (60 points) and elective units (12 points).

Core units

Students must complete:

• MPH5020 Introduction to epidemiology and biostatistics
• PGC5001 Evidence based practice
• PGC5007 Introduction to clinical research
• PGC5008 Clinical research 2
• PGC5009 Clinical research 3
• PGW5101 Biology of wound healing
• PGW5102 Wound assessment
• PGW5103 Wound dressings
• PGW5104 Management of acute wounds
• PGW5105 Management of chronic wounds
• PGW5106 Systemic medication and wound healing
• PGW5108 Nutrition and wound healing
• PGW5122 Advanced clinical practice in wound care
• PGW5127 Practical wound care training and assessment

Elective units

Students must complete 12 points from:

• PGP5014 Clinical educator preparation
• PGW5109 Dermatology
• PGW5111 Alternative therapies
• PGW5112 Scar management
• PGW5113 Non-healing ulcers and pain management
• PGW5116 Diabetic foot
• PGW5123 Management of burns
• PGW5126 Clinical risk management and wound care
• PGW5130 Pressure injury prediction, prevention and management

Research component

Students must have achieved a minimum grade of 65 per cent in MPH5020 (Introduction to epidemiology and biostatistics) and PGC5001 (Evidence based practice) to enrol in PGC5007 (Introduction to clinical research).

Students are required to develop a research proposal for a wound-related project, write a project proposal, and write and submit an ethics proposal and gain ethics approval from their practice site and/or from Monash University.

Students will present work-in-progress to a panel, conduct a literature review, present a final verbal report of the research undertaken and submit a written report of their research project.

Minimum grade for course completion

In order to successfully complete this course, students must achieve a minimum pass grade as follows:

(a.) credit (60) in:

• PGW5101 Biology of wound healing
• PGW5102 Wound assessment
• PGW5103 Wound dressings
• PGW5104 Management of acute wounds
• PGW5105 Management of chronic wounds
• PGW5106 Systemic medication and wound healing
• PGW5108 Nutrition and wound healing
• elective unit(s) equivalent to 12 credit points.

(b.) credit (65) in:

• PGC5001 Evidence based practice
• MPH5020 Introduction to epidemiology and biostatistics

(c.) distinction (70) in PGW5127 Practical wound care training and assessment.

Students wishing to exit this course early or who do not achieve the minimum pass grade for course completion exit with one of the following, provided they have satisfied the requirements for that award:

• 2982 Graduate Certificate in Wound Care after successful completion of 24 points of study
• 2984 Graduate Diploma in Wound Care after successful completion of 48 points of study.

This course provides research opportunities in any of the principal areas of research in the broad field of pharmaceutical science. Project availability is conditional upon the availability of materials, equipment and supervisors. Students are advised to consult with a potential supervisor regarding their choice of topic.

These course outcomes are aligned with the Australian Qualifications Framework level 9, the Bologna Cycle 2 and Monash Graduate AttributesAustralian Qualifications Framework level 9, the Bologna Cycle 2 and Monash Graduate Attributes (http://monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).

Upon successful completion of this course it is expected that graduates will be able to:

• produce a thesis that displays competence in understanding and carrying out research in the field of pharmaceutical science (but with less emphasis on comprehensive knowledge and originality as required in a PhD)
• devise a research topic to investigate a particular pharmaceutical science research area
• identify key research questions that are not too general and ambitious
• select and review relevant theory and literature
• design a study and choose appropriate methods to investigate the specific research questions
• select appropriate modes of analysis
• consider ethical issues involved in research
• implement, critically appraise or apply research in a particular field
• prepare a comprehensive written report that is professionally presented and contains all the required components of a master's thesis, including a bibliography.

This course consists of a research and thesis component undertaken in any of the Faculty of Pharmacy and Pharmaceutical Sciences research areas.

Students must, in consultation with and under the direct supervision of a member/s of the academic staff:

(1.) carry out a program of research on an agreed topic approved by the faculty in the student's chosen discipline for a specified period, including attending and/or presenting at seminars and other related activities as indicated by the faculty

(2.) submit for assessment a thesis of not more than 20,000 words on the program of research which meets the requirements of the examiners. Submission of the thesis based on or partially based on conjointly published or unpublished work is permitted.

Students enrol in the appropriate research unit relevant to their field:

• PRU0001 Research in medicinal chemistry
• PRU0002 Research in pharmacology
• PRU0003 Research in pharmaceutics
• PRU0004 Research in pharmacy practice

Students are required to undertake regular progress milestones to support them in conducting research of an appropriate quality, originality and depth as required by their course of study, in accordance with the Graduate Research Progress Management policyGraduate Research Progress Management policy (http://policy.monash.edu/policy-bank/academic/research/mrgs/grad-research-progress-mgmt-policy.html) and supporting procedures.

Enrolment in a Doctor of Philosophy involves the independent investigation of a research problem that has been formulated by the student. It is expected that the research undertaken will make a significant contribution to the discipline in which the student is enrolled. Doctoral students are supported by a minimum of two supervisors throughout their enrolment.

Students are also required to complete training activities as part of the Monash doctoral programMonash doctoral program (http://www.monash.edu/migr/future-students/phd). These discipline-specific and professional development activities are designed to impart skills and knowledge that will assist students to conduct their research.

These course outcomes are aligned with the Australian Qualifications Framework level 9, the Bologna Cycle 3 and Monash Graduate AttributesAustralian Qualifications Framework level 10, the Bologna Cycle 3 and Monash Graduate Attributes (http://monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).

Successful completion of the program will signify that the holder has completed a course of postgraduate training in research under proper academic supervision and has submitted a thesis that the examiners have declared to be a significant contribution to knowledge and which demonstrates the student's capacity to carry out independent original research.

Conditions of enrolment

Students are to refer to the Handbook for Doctoral DegreesHandbook for Doctoral Degrees (http://www.monash.edu/migr/faqs-and-resources/content) for all policies and procedures relating to their enrolment.

This course consists of:

• a research and thesis component
• a professional development training program.

Students must, in consultation with and under the direct supervision of a member/s of the academic staff:

(1.) carry out a program of research on an agreed topic approved by the faculty in the student's chosen discipline for a specified period, including attending and/or presenting at seminars and other related activities as indicated by the faculty

(2.) submit for assessment a thesis of not more than 80,000 words on the program of research which meets the requirements of the examiners. Submission of the thesis based on or partially based on conjointly published or unpublished workconjointly published or unpublished work (http://www.monash.edu.au/migr/examiners/publication/) may be permitted.

(3.) satisfactorily complete the program of professional development training as outlined under 'PhD programs' below.

Students are required to undertake regular progress milestones to support them in conducting research of an appropriate quality, originality and depth as required by their course of study, in accordance with the Graduate Research Progress Management policyGraduate Research Progress Management policy (http://policy.monash.edu/policy-bank/academic/research/mrgs/grad-research-progress-mgmt-policy.html) and supporting procedures.

PhD programs

• Pharmacy and pharmaceutical sciences PhD program